Hillrom Reports Strong Third Quarter Financial Results

CHICAGO, July 31, 2020 - Hillrom (NYSE: HRC) today announced financial results for its fiscal third quarter ended June 30, 2020 and provided commentary on current business trends and outlook.

Hillrom Inks Partnership With Aiva To Facilitate Voice-Enabled Clinical Workflows

CHICAGO, July 28, 2020 - Hillrom (NYSE: HRC) today announced a new commercial partnership with Aiva, enabling hands-free communication for both patients and staff utilizing an in-room voice assistant and Hillrom's Voalte® Mobile solution.

Hillrom Launches New Surgical Positioning Innovations

CHICAGO, July 20, 2020- Global medical technology leader Hillrom (NYSE: HRC) announced the full commercial launch of the PST 500, a precision surgical table, and a highly advanced addition to the Yellofins® Stirrups line, Yellofins Apex™.

Hillrom Declares Fiscal 2020 Fourth Quarter Dividend

CHICAGO, July 15, 2020 - Hillrom (NYSE: HRC) announced today that its board of directors declared a fiscal 2020 fourth quarter dividend of $0.22 per share payable on September 30, 2020, to shareholders of record as of the close of business on September 18, 2020. The indicated annual dividend rate is $0.88 per share.

Hillrom Launches Two New Respiratory Health Innovations: Volara™ System for Oscillation and Lung Expansion Therapy, and Synclara™ Cough System

CHICAGO, July 13, 2020 - Global medical technology leader Hillrom (NYSE: HRC) today announced the launch of two new respiratory therapy devices: the Volara™ System, which provides hospital-grade oscillation and lung expansion (OLE) therapy, and the Synclara™ Cough System.